Year |
Citation |
Score |
2024 |
Singh S, Wright RE, Giri S, Arumugaswami V, Kumar A. Targeting ABCG1 and SREBP-2 mediated cholesterol homeostasis ameliorates Zika virus-induced ocular pathology. Iscience. 27: 109088. PMID 38405605 DOI: 10.1016/j.isci.2024.109088 |
0.33 |
|
2023 |
Cui Q, Jeyachandran AV, Garcia G, Qin C, Zhou Y, Zhang M, Wang C, Sun G, Liu W, Zhou T, Feng L, Palmer C, Li Z, Aziz A, Gomperts BN, ... ... Arumugaswami V, et al. The Apolipoprotein E neutralizing antibody inhibits SARS-CoV-2 infection by blocking cellular entry of lipoviral particles. Medcomm. 4: e400. PMID 37822714 DOI: 10.1002/mco2.400 |
0.309 |
|
2023 |
Jeyachandran AV, Irudayam JI, Dubey S, Chakravarty N, Konda B, Shah A, Su B, Wang C, Cui Q, Williams KJ, Srikanth S, Shi Y, Deb A, Damoiseaux R, Stripp BR, ... ... Arumugaswami V, et al. Comparative Analysis of Molecular Pathogenic Mechanisms and Antiviral Development Targeting Old and New World Hantaviruses. Biorxiv : the Preprint Server For Biology. PMID 37577539 DOI: 10.1101/2023.08.04.552083 |
0.337 |
|
2023 |
Garcia G, Irudayam JI, Jeyachandran AV, Dubey S, Chang C, Castillo Cario S, Price N, Arumugam S, Marquez AL, Shah A, Fanaei A, Chakravarty N, Joshi S, Sinha S, French SW, ... ... Arumugaswami V, et al. Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses. Cell Reports. Medicine. 101024. PMID 37119814 DOI: 10.1016/j.xcrm.2023.101024 |
0.667 |
|
2023 |
Garcia G, Irudayam JI, Jeyachandran AV, Dubey S, Chang C, Cario SC, Price N, Arumugam S, Marquez AL, Shah A, Fanaei A, Chakravarty N, Joshi S, Sinha S, French SW, ... ... Arumugaswami V, et al. Broad-spectrum antiviral inhibitors targeting pandemic potential RNA viruses. Biorxiv : the Preprint Server For Biology. PMID 36711787 DOI: 10.1101/2023.01.19.524824 |
0.689 |
|
2022 |
Garcia G, Jeyachandran AV, Wang Y, Irudayam JI, Cario SC, Sen C, Li S, Li Y, Kumar A, Nielsen-Saines K, French SW, Shah PS, Morizono K, Gomperts BN, Deb A, ... ... Arumugaswami V, et al. Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response. Plos Biology. 20: e3001851. PMID 36346780 DOI: 10.1371/journal.pbio.3001851 |
0.331 |
|
2022 |
Garcia G, Chakravarty N, Abu AE, Jeyachandran AV, Takano KA, Brown R, Morizono K, Arumugaswami V. Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model. Microbiology Spectrum. e0113722. PMID 36169338 DOI: 10.1128/spectrum.01137-22 |
0.369 |
|
2022 |
Garcia G, Wang Y, Irudayam JI, Jeyachandran AV, Cario SC, Sen C, Li S, Li Y, Kumar A, Nielsen-Saines K, French SW, Shah PS, Morizono K, Gomperts B, Deb A, ... ... Arumugaswami V, et al. Hippo Signaling Pathway Activation during SARS-CoV-2 Infection Contributes to Host Antiviral Response. Biorxiv : the Preprint Server For Biology. PMID 35441167 DOI: 10.1101/2022.04.07.487520 |
0.326 |
|
2022 |
Petcherski A, Sharma M, Daskou M, Satta S, Vasilopoulos H, Hugo C, Ritou E, Dillon BJ, Fung E, Garcia G, Scafoglio C, Purkayastha A, Gomperts BN, Fishbein GA, Arumugaswami V, et al. Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways. Biorxiv : the Preprint Server For Biology. PMID 35233569 DOI: 10.1101/2022.02.22.481100 |
0.303 |
|
2021 |
Luu AP, Yao Z, Ramachandran S, Azzopardi SA, Miles LA, Schneider WM, Hoffmann HH, Bozzacco L, Garcia G, Gong D, Damoiseaux R, Tang H, Morizono K, Rudin CM, Sun R, ... Arumugaswami V, et al. A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry. Viruses. 13. PMID 34834920 DOI: 10.3390/v13112113 |
0.39 |
|
2021 |
Sun G, Cui Q, Garcia G, Wang C, Zhang M, Arumugaswami V, Riggs AD, Shi Y. Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses. Scientific Reports. 11: 17146. PMID 34433867 DOI: 10.1038/s41598-021-96462-w |
0.35 |
|
2021 |
Chen F, Shi Q, Pei F, Vogt A, Porritt RA, Garcia G, Gomez AC, Cheng MH, Schurdak ME, Liu B, Chan SY, Arumugaswami V, Stern AM, Taylor DL, Arditi M, et al. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Molecular Systems Biology. 17: e10239. PMID 34339582 DOI: 10.15252/msb.202110239 |
0.339 |
|
2021 |
Song DH, Garcia G, Situ K, Chua BA, Hong MLO, Do EA, Ramirez CM, Harui A, Arumugaswami V, Morizono K. Development of a blocker of the universal phosphatidylserine- and phosphatidylethanolamine-dependent viral entry pathways. Virology. 560: 17-33. PMID 34020328 DOI: 10.1016/j.virol.2021.04.013 |
0.349 |
|
2021 |
Garcia G, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, ... ... Arumugaswami V, et al. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Reports. 108940. PMID 33784499 DOI: 10.1016/j.celrep.2021.108940 |
0.609 |
|
2020 |
Sharma A, Garcia G, Wang Y, Plummer JT, Morizono K, Arumugaswami V, Svendsen CN. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Reports. Medicine. 1: 100052. PMID 32835305 DOI: 10.1016/j.xcrm.2020.100052 |
0.325 |
|
2020 |
Singh S, Singh PK, Suhail H, Arumugaswami V, Pellett PE, Giri S, Kumar A. AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis. Journal of Immunology (Baltimore, Md. : 1950). PMID 32086387 DOI: 10.4049/Jimmunol.1901310 |
0.355 |
|
2020 |
Martínez LE, Garcia G, Contreras D, Gong D, Sun R, Arumugaswami V. Zika Virus Mucosal Infection Provides Protective Immunity. Journal of Virology. PMID 32051274 DOI: 10.1128/JVI.00067-20 |
0.368 |
|
2020 |
Garcia G, Paul S, Beshara S, Ramanujan VK, Ramaiah A, Nielsen-Saines K, Li MMH, French SW, Morizono K, Kumar A, Arumugaswami V. Hippo Signaling Pathway has a critical role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation. The American Journal of Pathology. PMID 32035058 DOI: 10.1096/Fasebj.2020.34.S1.06590 |
0.312 |
|
2019 |
Thaker SK, Chapa T, Garcia G, Gong D, Schmid EW, Arumugaswami V, Sun R, Christofk HR. Differential Metabolic Reprogramming by Zika Virus Promotes Cell Death in Human versus Mosquito Cells. Cell Metabolism. PMID 30827860 DOI: 10.1016/j.cmet.2019.01.024 |
0.353 |
|
2018 |
Gong D, Zhang TH, Zhao D, Du Y, Chapa TJ, Shi Y, Wang L, Contreras D, Zeng G, Shi PY, Wu TT, Arumugaswami V, Sun R. High-Throughput Fitness Profiling of Zika Virus E Protein Reveals Different Roles for Glycosylation during Infection of Mammalian and Mosquito Cells. Iscience. 1: 97-111. PMID 30227960 DOI: 10.1016/j.isci.2018.02.005 |
0.416 |
|
2018 |
Khachatoorian R, Cohn W, Buzzanco A, Riahi R, Arumugaswami V, Dasgupta A, Whitelegge JP, French SW. HSP70 Copurifies with Zika Virus Particles. Virology. 522: 228-233. PMID 30053656 DOI: 10.1016/J.Virol.2018.07.009 |
0.34 |
|
2018 |
Singh PK, Khatri I, Jha A, Pretto CD, Spindler KR, Arumugaswami V, Giri S, Kumar A, Bhasin MK. Determination of system level alterations in host transcriptome due to Zika virus (ZIKV) Infection in retinal pigment epithelium. Scientific Reports. 8: 11209. PMID 30046058 DOI: 10.1038/s41598-018-29329-2 |
0.404 |
|
2017 |
Ramaiah A, Dai L, Contreras D, Sinha S, Sun R, Arumugaswami V. Comparative analysis of protein evolution in the genome of pre-epidemic and epidemic Zika virus. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 28315476 DOI: 10.1016/j.meegid.2017.03.012 |
0.357 |
|
2016 |
Contreras D, Arumugaswami V. Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons. Journal of Visualized Experiments : Jove. PMID 27584546 DOI: 10.3791/54767 |
0.383 |
|
2016 |
Ramaiah A, Arumugaswami V. Ebolavirus evolves in human to minimize the detection by immune cells by accumulating adaptive mutations. Virusdisease. 27: 136-44. PMID 27366764 DOI: 10.1007/s13337-016-0305-0 |
0.303 |
|
2016 |
Khachatoorian R, Riahi R, Ganapathy E, Shao H, Wheatley NM, Sundberg C, Jung CL, Ruchala P, Dasgupta A, Arumugaswami V, Gestwicki JE, French SW. Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly. International Journal of Antimicrobial Agents. PMID 27013001 DOI: 10.1016/J.Ijantimicag.2016.01.012 |
0.329 |
|
2012 |
Noh CW, Cho HJ, Kang HR, Jin HY, Lee S, Deng H, Wu TT, Arumugaswami V, Sun R, Song MJ. The virion-associated open reading frame 49 of murine gammaherpesvirus 68 promotes viral replication both in vitro and in vivo as a derepressor of RTA. Journal of Virology. 86: 1109-18. PMID 22090108 DOI: 10.1128/Jvi.05785-11 |
0.42 |
|
2009 |
Arumugaswami V, Kumar PM, Konjufca V, Dienglewicz RL, Reddy SM, Parcells MS. Latency of Marek's disease virus (MDV) in a reticuloendotheliosis virus-transformed T-cell line. II: expression of the latent MDV genome. Avian Diseases. 53: 156-65. PMID 19630218 DOI: 10.1637/8384-062308-Reg.1 |
0.709 |
|
2009 |
Arumugaswami V, Kumar PM, Konjufca V, Dienglewicz RL, Reddy SM, Parcells MS. Latency of Marek's disease virus (MDV) in a reticuloendotheliosis virus-transformed T-cell line. I: uptake and structure of the latent MDV genome. Avian Diseases. 53: 149-55. PMID 19630217 DOI: 10.1637/8383-062308-Reg.1 |
0.714 |
|
2009 |
Gong D, Qi J, Arumugaswami V, Sun R, Deng H. Identification and functional characterization of the left origin of lytic replication of murine gammaherpesvirus 68. Virology. 387: 285-95. PMID 19285330 DOI: 10.1016/j.virol.2009.02.029 |
0.33 |
|
2009 |
Arumugaswami V, Sitapara R, Hwang S, Song MJ, Ho TN, Su NQ, Sue EY, Kanagavel V, Xing F, Zhang X, Zhao M, Deng H, Wu TT, Kanagavel S, Zhang L, et al. High-resolution functional profiling of a gammaherpesvirus RTA locus in the context of the viral genome. Journal of Virology. 83: 1811-22. PMID 19073723 DOI: 10.1128/Jvi.02302-08 |
0.327 |
|
2008 |
Arumugaswami V, Remenyi R, Kanagavel V, Sue EY, Ngoc Ho T, Liu C, Fontanes V, Dasgupta A, Sun R. High-resolution functional profiling of hepatitis C virus genome. Plos Pathogens. 4: e1000182. PMID 18927624 DOI: 10.1371/Journal.Ppat.1000182 |
0.304 |
|
2006 |
Arumugaswami V, Wu TT, Martinez-Guzman D, Jia Q, Deng H, Reyes N, Sun R. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. Journal of Virology. 80: 9730-40. PMID 16973577 DOI: 10.1128/JVI.00246-06 |
0.411 |
|
2006 |
Santin ER, Shamblin CE, Prigge JT, Arumugaswami V, Dienglewicz RL, Parcells MS. Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis. Avian Diseases. 50: 96-103. PMID 16617990 DOI: 10.1637/7273-090704R1.1 |
0.641 |
|
2006 |
Anobile JM, Arumugaswami V, Downs D, Czymmek K, Parcells M, Schmidt CJ. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. Journal of Virology. 80: 1160-6. PMID 16414993 DOI: 10.1128/Jvi.80.3.1160-1166.2006 |
0.669 |
|
2004 |
Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Veterinary Microbiology. 102: 147-67. PMID 15327791 DOI: 10.1016/J.Vetmic.2004.06.007 |
0.726 |
|
2003 |
Parcells MS, Arumugaswami V, Prigge JT, Pandya K, Dienglewicz RL. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication. Poultry Science. 82: 893-8. PMID 12817443 DOI: 10.1093/Ps/82.6.893 |
0.652 |
|
Show low-probability matches. |